The leukotriene receptor antagonist montelukast and its possible role in the cardiovascular field
Sign Up to like & getrecommendations! Published in 2017 at "European Journal of Clinical Pharmacology"
DOI: 10.1007/s00228-017-2242-2
Abstract: BackgroundCysteinyl leukotrienes (LTC4, LTD4, and LTE4) are pro-inflammatory mediators of the 5-lipooxygenase (5-LO) pathway, that play an important role in bronchoconstriction, but can also enhance endothelial cell permeability and myocardial contractility, and are involved in… read more here.
Keywords: receptor antagonist; leukotriene receptor; antagonist montelukast; role ... See more keywords